The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance)

dc.contributor.authorLewis, Lionel D.
dc.contributor.authorMiller, Antonius A.
dc.contributor.authorOwzar, Kouros
dc.contributor.authorBies, Robert R.
dc.contributor.authorMarkova, Svetlana
dc.contributor.authorJiang, Chen
dc.contributor.authorKroetz, Deanna L.
dc.contributor.authorEgorin, Merrill J.
dc.contributor.authorMcLeod, Howard L.
dc.contributor.authorRatain, Mark J.
dc.contributor.authorAlliance for Clinical Trials in Oncology
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2025-06-06T13:48:43Z
dc.date.available2025-06-06T13:48:43Z
dc.date.issued2013
dc.description.abstractDocetaxel-related neutropenia was associated with polymorphisms in the drug transporters ABCC2 and SLCO1B3 in Japanese cancer patients. We hypothesized that this association is because of reduced docetaxel clearance, associated with polymorphisms in those genes. We studied 64 US cancer patients who received a single cycle of 75 mg/m of docetaxel monotherapy. We found that the ABCC2 polymorphism at rs-12762549 trended to show a relationship with reduced docetaxel clearance (P=0.048), but not with neutropenia. There was no significant association of the SLCO1B3 polymorphisms with docetaxel clearance or neutropenia. We conclude that the relationship between docetaxel-associated neutropenia and polymorphisms in drug transporters identified in Japanese patients was not confirmed in this cohort of US cancer patients.
dc.eprint.versionAuthor's manuscript
dc.identifier.citationLewis LD, Miller AA, Owzar K, et al. The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance). Pharmacogenet Genomics. 2013;23(1):29-33. doi:10.1097/FPC.0b013e32835b16d8
dc.identifier.urihttps://hdl.handle.net/1805/48545
dc.language.isoen_US
dc.publisherWolters Kluwer
dc.relation.isversionof10.1097/FPC.0b013e32835b16d8
dc.relation.journalPharmacogenetics and Genomics
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectABCC2 (pharmacogenetics)
dc.subjectDocetaxel
dc.subjectNeutropenia
dc.subjectPharmacokinetics
dc.subjectSLCO1B3
dc.titleThe relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance)
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Lewis213Relationship-AAM.pdf
Size:
346.2 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: